Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Babaodan** is a Chinese proprietary multi-ingredient traditional medicine marketed by Xiamen Traditional Chinese Medicine as an oral hard-capsule product. The capsule contains a proprietary mixture including Calculus Bovis, snake gall, antelope horn, pearl, notoginseng, and musk; the full formulation and manufacturing process are not completely disclosed. Its labeled traditional indications include syndromes associated with viral hepatitis, acute cholecystitis, and acute urinary tract infection, with traditional functions described as clearing damp-heat, promoting blood circulation and detoxification, and relieving jaundice and pain. The product has also been evaluated clinically as an adjunctive agent for prevention of hepatocellular carcinoma recurrence after curative hepatectomy and in several other liver-related and inflammatory conditions. ([dinglu.com.cn](https://www.dinglu.com.cn/produce-detail/31))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Babaodan.